Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Elan Corporation, plc (ELN) -- Ignore unavailable to you. Want to Upgrade?

To: tom pope who wrote (9998)	10/24/2008 11:04:12 AM
From: tom pope	Respond to of 10345

To: tom pope who wrote (9998)	10/24/2008 12:22:22 PM
From: Arthur Radley	Read Replies (1) \| Respond to of 10345

Tom, One would have to believe that ELN would be a buy sub-$7.00, however, knowing of the banking situation in Ireland because of another company that I follow --ELN's future lies with them being able to reduce their debt load...and soon! The fact that they have basically admitted there will be no quick sell of their drug development operation only makes the looming debt issue a major issue for them. Adding the odds of another PML problem and their debt load....the only near term solution I can see...is BIIB taking them out. IMO, one merely has to look at the cash load many of the big pharma have in the bank....buyouts will be forthcoming from the likes of PFE, WYE, and GSK. Look at recent statements from GSK...they are on the prowl because they have the money and need a pipeline. What GSK said this week is that biotechs are coming to them in hordes...seeking a buyout! Cash is king, now! That is the issue with ELAN. Good luck, should you buy!